168 related articles for article (PubMed ID: 37924907)
1. Structural insights into the co-aggregation of Aβ and tau amyloid core peptides: Revealing potential pathological heterooligomers by simulations.
Li X; Chen Y; Yang Z; Zhang S; Wei G; Zhang L
Int J Biol Macromol; 2024 Jan; 254(Pt 2):127841. PubMed ID: 37924907
[TBL] [Abstract][Full Text] [Related]
2. Deciphering the Inhibitory Mechanism of Naphthoquinone-Dopamine on the Aggregation of Tau Core Fragments PHF6* and PHF6.
Zou Y; Qi B; Tan J; Guan L; Zhang Q; Sun Y; Huang F
ACS Chem Neurosci; 2023 Sep; 14(17):3265-3277. PubMed ID: 37585669
[TBL] [Abstract][Full Text] [Related]
3. Effects of All-Atom Molecular Mechanics Force Fields on Amyloid Peptide Assembly: The Case of PHF6 Peptide of Tau Protein.
Man VH; He X; Gao J; Wang J
J Chem Theory Comput; 2021 Oct; 17(10):6458-6471. PubMed ID: 34491058
[TBL] [Abstract][Full Text] [Related]
4. Atomistic Insights into the Inhibitory Mechanism of Tyrosine Phosphorylation against the Aggregation of Human Tau Fragment PHF6.
Zou Y; Guan L; Tan J; Qi B; Wang Y; Zhang Q; Sun Y
J Phys Chem B; 2023 Jan; 127(1):335-345. PubMed ID: 36594671
[TBL] [Abstract][Full Text] [Related]
5. Effects of hydroxylated carbon nanotubes on the aggregation of Aβ16-22 peptides: a combined simulation and experimental study.
Xie L; Lin D; Luo Y; Li H; Yang X; Wei G
Biophys J; 2014 Oct; 107(8):1930-1938. PubMed ID: 25418174
[TBL] [Abstract][Full Text] [Related]
6. Unraveling the Influence of K280 Acetylation on the Conformational Features of Tau Core Fragment: A Molecular Dynamics Simulation Study.
Zou Y; Guan L
Front Mol Biosci; 2021; 8():801577. PubMed ID: 34966788
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic insight into E22Q-mutation-induced antiparallel-to-parallel β-sheet transition of Aβ
Li X; Lei J; Qi R; Xie L; Wei G
Phys Chem Chem Phys; 2019 Jul; 21(28):15686-15694. PubMed ID: 31271401
[TBL] [Abstract][Full Text] [Related]
8. Deciphering the Role of ATP on PHF6 Aggregation.
Pal S; Roy R; Paul S
J Phys Chem B; 2022 Jul; 126(26):4761-4775. PubMed ID: 35759245
[TBL] [Abstract][Full Text] [Related]
9. Disclosing the Mechanism of Spontaneous Aggregation and Template-Induced Misfolding of the Key Hexapeptide (PHF6) of Tau Protein Based on Molecular Dynamics Simulation.
Liu H; Zhong H; Liu X; Zhou S; Tan S; Liu H; Yao X
ACS Chem Neurosci; 2019 Dec; 10(12):4810-4823. PubMed ID: 31661961
[TBL] [Abstract][Full Text] [Related]
10. Primary Fibril Nucleation of Aggregation Prone Tau Fragments PHF6 and PHF6.
Smit FX; Luiken JA; Bolhuis PG
J Phys Chem B; 2017 Apr; 121(15):3250-3261. PubMed ID: 27776213
[TBL] [Abstract][Full Text] [Related]
11. Norepinephrine Inhibits Alzheimer's Amyloid-β Peptide Aggregation and Destabilizes Amyloid-β Protofibrils: A Molecular Dynamics Simulation Study.
Zou Y; Qian Z; Chen Y; Qian H; Wei G; Zhang Q
ACS Chem Neurosci; 2019 Mar; 10(3):1585-1594. PubMed ID: 30605312
[TBL] [Abstract][Full Text] [Related]
12. Heparin remodels the microtubule-binding repeat R3 of Tau protein towards fibril-prone conformations.
Dong X; Qi R; Qiao Q; Li X; Li F; Wan J; Zhang Q; Wei G
Phys Chem Chem Phys; 2021 Sep; 23(36):20406-20418. PubMed ID: 34494046
[TBL] [Abstract][Full Text] [Related]
13. Purpurin modulates Tau-derived VQIVYK fibrillization and ameliorates Alzheimer's disease-like symptoms in animal model.
Viswanathan GK; Shwartz D; Losev Y; Arad E; Shemesh C; Pichinuk E; Engel H; Raveh A; Jelinek R; Cooper I; Gosselet F; Gazit E; Segal D
Cell Mol Life Sci; 2020 Jul; 77(14):2795-2813. PubMed ID: 31562564
[TBL] [Abstract][Full Text] [Related]
14. ATP Controls the Aggregation of Aβ
Pal S; Paul S
J Phys Chem B; 2020 Jan; 124(1):210-223. PubMed ID: 31830415
[TBL] [Abstract][Full Text] [Related]
15. Integrating in vitro and in silico approaches to evaluate the "dual functionality" of palmatine chloride in inhibiting and disassembling Tau-derived VQIVYK peptide fibrils.
Haj E; Losev Y; Guru KrishnaKumar V; Pichinuk E; Engel H; Raveh A; Gazit E; Segal D
Biochim Biophys Acta Gen Subj; 2018 Jul; 1862(7):1565-1575. PubMed ID: 29634991
[TBL] [Abstract][Full Text] [Related]
16. The Effects of Different Glycosaminoglycans on the Structure and Aggregation of the Amyloid-β (16-22) Peptide.
Samantray S; Strodel B
J Phys Chem B; 2021 Jun; 125(21):5511-5525. PubMed ID: 34027669
[TBL] [Abstract][Full Text] [Related]
17. Zn
Song Y; Wu M; Wang C; Fang H; Lei X
J Phys Chem B; 2024 Feb; 128(6):1385-1393. PubMed ID: 38294417
[TBL] [Abstract][Full Text] [Related]
18. Terminal Capping of an Amyloidogenic Tau Fragment Modulates Its Fibrillation Propensity.
Arya S; Ganguly P; Arsiccio A; Claud SL; Trapp B; Schonfeld GE; Liu X; Lazar Cantrell K; Shea JE; Bowers MT
J Phys Chem B; 2020 Oct; 124(40):8772-8783. PubMed ID: 32816481
[TBL] [Abstract][Full Text] [Related]
19. Molecular dynamics simulations reveal the disruption mechanism of a 2,4-thiazolidinedione derivative C30 against tau hexapeptide (PHF6) oligomer.
Liu H; Zhong H; Liu H; Yao X
Proteins; 2022 Jan; 90(1):142-154. PubMed ID: 34331342
[TBL] [Abstract][Full Text] [Related]
20. The inhibitory mechanism of a fullerene derivative against amyloid-β peptide aggregation: an atomistic simulation study.
Sun Y; Qian Z; Wei G
Phys Chem Chem Phys; 2016 May; 18(18):12582-91. PubMed ID: 27091578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]